SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-22-002407
Filing Date
2022-03-24
Accepted
2022-03-24 16:54:28
Documents
2
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1768
2 ex24miyashita.txt EX-24 4484
  Complete submission text file 0001179110-22-002407.txt   7831
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20725 S. WESTERN AVENUE SUITE 136 TORRANCE CA 90501
Business Address
Miyashita Akiko Moni (Reporting) CIK: 0001607742 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32335 | Film No.: 22767198